28. Referanser

Agarwal, J. P., Nemade, B., Murthy, V., Ghosh-Laskar, S., Budrukkar, A., Gupta, T., D'Cruz, A., Pai, P., ... Dinshaw, K. (2008). Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiotherapy and Oncology, 89(1), 51-6.

Ahn, P. H., Mitra, N., Alonso-Basanta, M., Palmer, J. N., Adappa, N. D., O'Malley, B. W. ,. J., Rassekh, C., Chalian, A., ... Lin, A. (2016). Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis. Acta Oncologica, 55(9-10), 1107-1114.

Aiken, A. H., Rath, T. J., Anzai, Y., Branstetter, B. F., Hoang, J. K., Wiggins, R. H., Juliano, A. F., Glastonbury, C., ... Hudgins, P. A. (2018). ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee. Journal of the American College of Radiology : JACR, 15(8), 1097-1108.

Akbaba, S., Lang, K., Held, T., Herfarth, K., Rieber, J., Plinkert, P., Auffarth, G. U., Rieken, S., ... Adeberg, S. (2019). Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety. Cancer Management and Research, 11, 1155-1166.

Al-Mamgani, A., van Rooij, P., Mehilal, R., Tans, L., & Levendag, P. C. (2013). Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. European Archives of Oto-Rhino-Laryngology, 270(1), 293-9.

Alsibani, A., Alqahtani, A., Almohammadi, R., Islam, T., Alessa, M., Aldhahri, S. F., & Al-Qahtani, K. H. (2024). Comparing the Efficacy of CT, MRI, PET-CT, and US in the Detection of Cervical Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma with Clinically Negative Neck Lymph Node: A Systematic Review and Meta-Analysis. Journal of clinical medicine, 13(24)

Ambrosch, P. (2007). The role of laser microsurgery in the treatment of laryngeal cancer. Current Opinion in Otolaryngology & Head and Neck Surgery, 15(2), 82-8.

American Cancer Society (9. oktober 2018). Merkel Cell Carcinoma Stages. [nettdokument]. Atlanta, GA: American Cancer Society. Hentet 17. desember 2018 fra https://www.cancer.org/cancer/merkel-cell-skin-cancer/detection-diagnosis-staging/staging.html

Amin, M. B., Edge, S. B., Greene, F. L. (2017). AJCC cancer staging manual. Springer.

Amit, M., Abdelmeguid, A. S., Watcherporn, T., Takahashi, H., Tam, S., Bell, D., Ferrarotto, R., Glisson, B., ... Hanna, E. Y. (2019). Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. Journal of Clinical Oncology, 37(6), 504-512.

Amols, H. I., Lagueux, B., & Cagna, D. (1986). Radiobiological effectiveness (RBE) of megavoltage X-ray and electron beams in radiotherapy. Radiation Research, 105(1), 58-67.

Ang, K., Zhang, Q., Wheeler, R. H., Rosenthal, D. I., Nguyen-Tan, F., Kim, H., Lu, C., Axelrod, R. S., ... Weber, R. S. (2010). A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): Impact of radiation and cisplatin intensity on outcome. Journal of Clinical Oncology, 28(15 SUPPL. 1), 5507.

Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tan, P. F., Westra, W. H., Chung, C. H., ... Gillison, M. L. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine, 363(1), 24-35.

Anzai, Y., Chang, C. P., Rowe, K., Snyder, J., Deshmukh, V., Newman, M., Fraser, A., Smith, K., ... Hashibe, M. (2023). Surveillance Imaging with PET/CT and CT and/or MRI for Head and Neck Cancer and Mortality: A Population-based Study. Radiology, 307(2), e212915.

Arya, S., Rane, P., & Deshmukh, A. (2014). Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management. Clinical Radiology, 69(9), 916-30.

Avdeling for funksjonsvurdering (30. august 2022). Spise- og svelgevansker - vurderingsopphold. [nettside]. Bjørnemyr: Sunnaas sykehus. Hentet 2. mai 2023 fra https://www.sunnaas.no/behandlinger/spise-og-svelgvansker-vurderingsopphold

Bakst, R. L., Su, W., Ozbek, U., Knoll, M. A., Miles, B. A., Gupta, V., & Rhome, R. (2017). Adjuvant radiation for salivary gland malignancies is associated with improved survival: A National Cancer Database analysis. Advances in radiation oncology, 2(2), 159-166.

Bauml, J. M., Vinnakota, R., Anna Park, Y. H., Bates, S. E., Fojo, T., Aggarwal, C., Limaye, S., Damjanov, N., ... Sigel, K. (2019). Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. Journal of the National Cancer Institute, 111(5), 490-497.

Becker, M., Zbären, P., Casselman, J. W., Kohler, R., Dulguerov, P., & Becker, C. D. (2008). Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging. Radiology, 249(2), 551-9.

Bentz, B. G., Bilsky, M. H., Shah, J. P., & Kraus, D. (2003). Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience. Head and Neck, 25(7), 515-20.

Bentzen, J. D., & Hansen, H. S. (2007). Phase II analysis of paclitaxel and capecitabine in the treatment of recurrent or disseminated squamous cell carcinoma of the head and neck region. Head and Neck, 29(1), 47-51.

Bernier, J., Cooper, J. S., Pajak, T. F., van Glabbeke, M., Bourhis, J., Forastiere, A., Ozsahin, E. M., Jacobs, J. R., ... Lefèbvre, J. L. (2005). Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head and Neck, 27(10), 843-50.

Bernier, J., Domenge, C., Ozsahin, M., Matuszewska, K., Lefèbvre, J. L., Greiner, R. H., Giralt, J., Maingon, P., ... van Glabbeke, M. (2004). Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. New England Journal of Medicine, 350(19), 1945-52.

Bhattacharyya, N., & Fried, M. P. (2002). Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Archives of Otolaryngology - Head and Neck Surgery, 128(8), 904-8.

Biau, J., Lapeyre, M., Troussier, I., Budach, W., Giralt, J., Grau, C., Kazmierska, J., Langendijk, J. A., ... Gregoire, V. (2019). Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiotherapy and Oncology, 134, 1-9.

Binazzi, A., Ferrante, P., & Marinaccio, A. (2015). Occupational exposure and sinonasal cancer: a systematic review and meta-analysis. BMC Cancer, 15, 49.

Blanchard, P., Bourhis, J., Lacas, B., Posner, M. R., Vermorken, J. B., Cruz Hernandez, J. J., Bourredjem, A., Calais, G., ... Pignon, J. P. (2013). Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. Journal of Clinical Oncology, 31(23), 2854-60.

Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., ... Ang, K. K. (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New England Journal of Medicine, 354(6), 567-78.

Boscolo-Rizzo, P., Schroeder, L., Romeo, S., & Pawlita, M. (2015). The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review. Clinical and Experimental Metastasis, 32(8), 835-45.

Bossi, P., Saba, N. F., Vermorken, J. B., Strojan, P., Pala, L., de Bree, R., Rodrigo, J. P., Lopez, F., ... Ferlito, A. (2015). The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treatment Reviews, 41(10), 836-43.

Bossi, P., Saba, N. F., Vermorken, J. B., Strojan, P., Pala, L., de Bree, R., Rodrigo, J. P., Lopez, F., ... Ferlito, A. (2015). The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treatment Reviews, 41(10), 836-43.

Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., Horiot, J. C., Le Maitre, A., ... Pignon, J. P. (2006). Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet, 368(9538), 843-54.

Brady, L. W., Perez, C. A. (1998). Principles and practice of radiation oncology. Lippincott-Ravens.

Brandstorp-Boesen, J., Falk, R. S., Boysen, M., & Brøndbo, K. (2014). Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center. European Archives of Oto-Rhino-Laryngology, 271(12), 3233-9.

Brandstorp-Boesen, J., Sørum Falk, R., Boysen, M., & Brøndbo, K. (2017). Impact of stage, management and recurrence on survival rates in laryngeal cancer. PloS One, 12(7), e0179371.

Brandstorp-Boesen, J., Sørum Falk, R., Folkvard Evensen, J., Boysen, M., & Brøndbo, K. (2016). Risk of Recurrence in Laryngeal Cancer. PloS One, 11(10), e0164068.

Breuninger, H., & Dietz, K. (1991). Prediction of subclinical tumor infiltration in basal cell carcinoma. Journal of Dermatologic Surgery and Oncology, 17(7), 574-8.

Brierley, J. D., Gospodarwicz, M. K., Wittekind, C. (2017). TNM : classification of malignant tumours. Wiley-Blackwell.

Brouwer, C. L., Steenbakkers, R. J., Bourhis, J., Budach, W., Grau, C., Gregoire, V., van Herk, M., Lee, A., ... Langendijk, J. A. (2015). CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiotherapy and Oncology, 117(1), 83-90.

Brøndbo, K., Boysen, M., & Natvig, K. (1997). Laserkirurgi ved larynxcancer (T1a glottis). Nytt behandlingsalternativ.. Tidsskrift for den Norske Legeforening, 117(28), 4070-1.

Brøndbo, K., Fridrich, K., & Boysen, M. (2007). Laser surgery of T1a glottic carcinomas; significance of resection margins. European Archives of Oto-Rhino-Laryngology, 264(6), 627-30.

Burtness, B., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., de Castro, G. ,. J., Psyrri, A., Basté, N., ... KEYNOTE-048 Investigators (2019). Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet, 394(10212), 1915-1928.

Cacicedo, J., Navarro, A., Alongi, F., Gómez de Iturriaga, A., Del Hoyo, O., Boveda, E., Casquero, F., Perez, J. F., & Bilbao, P. (2014). The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cancer Treatment Reviews, 40(1), 178-89.

Candela, F. C., Kothari, K., & Shah, J. P. (1990). Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head and Neck, 12(3), 197-203.

Chambers, K. J., Lehmann, A. E., Remenschneider, A., Dedmon, M., Meier, J., Gray, S. T., & Lin, D. T. (2015). Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. Journal of neurological surgery. Part B, Skull base, 76(2), 94-100.

Chambers, K. J., Lehmann, A. E., Remenschneider, A., Dedmon, M., Meier, J., Gray, S. T., & Lin, D. T. (2015). Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. Journal of neurological surgery. Part B, Skull base, 76(2), 94-100.

Chan, A. W. (2011-2024). Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy [pågående studie]. (NCT01586767). Hentet fra https://www.clinicaltrials.gov/study/NCT01586767

Chen, A. M., Bucci, M. K., Quivey, J. M., Garcia, J., Eisele, D. W., & Fu, K. K. (2006). Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. International Journal of Radiation Oncology, Biology, Physics, 66(4), 1044-50.

Chen, A. M., Farwell, D. G., Luu, Q., Cheng, S., Donald, P. J., & Purdy, J. A. (2011). Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 80(3), 669-76.

Chen, A. M., Harris, J. P., Gan, M., Nabar, R., Tjoa, T., Haidar, Y. M., Truong, A., Chow, D. S., & Armstrong, W. B. (2023). Posttreatment Surveillance Imaging After Radiation for Head and Neck Cancer. JAMA network open, 6(11), e2342825.

Cheraghlou, S., Torabi, S. J., Husain, Z. A., Otremba, M. D., Osborn, H. A., Mehra, S., Yarbrough, W. G., Burtness, B. A., & Judson, B. L. (2019). HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes. Laryngoscope, 129(3), 684-691.

Cheung, R. L., Russell, A. C., & Freeman, J. (2008). Does routine preoperative imaging of parotid tumours affect surgical management decision making?. Journal of otolaryngology - head & neck surgery, 37(3), 430-4.

Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., ... Perou, C. M. (2004). Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell, 5(5), 489-500.

Cianchetti, M., Mancuso, A. A., Amdur, R. J., Werning, J. W., Kirwan, J., Morris, C. G., & Mendenhall, W. M. (2009). Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope, 119(12), 2348-54.

Clark, R. R., Soutar, D. S., & Hunter, K. D. (2010). A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology, 57(1), 138-46.

Cohen, E. E. W., Soulières, D., Le Tourneau, C., Dinis, J., Licitra, L., Ahn, M. J., Soria, A., Machiels, J. P., ... KEYNOTE-040 investigators (2019). Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet, 393(10167), 156-167.

Cohen, R. B., Delord, J. P., Doi, T., Piha-Paul, S. A., Liu, S. V., Gilbert, J., Algazi, A. P., Damian, S., ... Keam, B. (2018). Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study. American Journal of Clinical Oncology, 41(11), 1083-1088.

Colevas, A. D. (2006). Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. Journal of Clinical Oncology, 24(17), 2644-52.

Colevas, A. D. (2015). Systemic Therapy for Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Journal of the National Comprehensive Cancer Network, 13(5), e37-48.

Collins, B., Abernethy, J., Barnes, L. (2010). Oral Malignant Melanoma. [nettdokument]. Newport Beach, Ca: Oral Cancer Foundation. Hentet 22. februar 2018 fra https://oralcancerfoundation.org/facts/rare/oral-malignant-melanoma/

Cooper, J. S., Pajak, T. F., Forastiere, A. A., Jacobs, J., Campbell, B. H., Saxman, S. B., Kish, J. A., Kim, H. E., ... Fu, K. K. (2004). Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New England Journal of Medicine, 350(19), 1937-44.

Cooper, J. S., Zhang, Q., Pajak, T. F., Forastiere, A. A., Jacobs, J., Saxman, S. B., Kish, J. A., Kim, H. E., ... Ang, K. K. (2012). Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 84(5), 1198-205.

Copper, M. P., Jovanovic, A., Nauta, J. J., Braakhuis, B. J., de Vries, N., van der Waal, I., & Snow, G. B. (1995). Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Archives of Otolaryngology - Head and Neck Surgery, 121(2), 157-60.

Corrêa, T. S., Matos, G. D. R., Segura, M., & Dos Anjos, C. H. (2018). Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab. Case Reports in Oncology, 11(2), 252-257.

Corry, J., Peters, L. J., Costa, I. D., Milner, A. D., Fawns, H., Rischin, D., & Porceddu, S. (2005). The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiotherapy and Oncology, 77(2), 137-42.

Cowey, C. L. (2013). Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyond. Dermatology and therapy, 3(1), 17-31.

D'Cruz, A. K., Vaish, R., Kapre, N., Dandekar, M., Gupta, S., Hawaldar, R., Agarwal, J. P., Pantvaidya, G., ... Badwe, R. (2015). Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. New England Journal of Medicine, 373(6), 521-9.

DAHANCA (2016). Behandling af planocellulært karcinom i mundhulen: nationale retningslinjer (3 utg.) Aarhus: DAHANCA.

DAHANCA (2016-2023). DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC [pågående studie]. (NCT02661152): Hentet fra https://clinicaltrials.gov/study/NCT02661152

DAHANCA (2018). DAHANCA Radiotherapy Guidelines Aarhus: DAHANCA.

DAHANCA (2020). Udredning og behandling af spytkirtelkræft [s.l.]: Danish Head and Neck cancer Study Group. Hentet fra https://www.dahanca.oncology.dk/uploads/TilFagfolk/Guideline/dahanca_spytkirtel_031120.pdf

DAHANCA (2021). Radiotherapy Guidelines 2020 [s.l.]: Danish Head and Neck cancer Study Group. Hentet fra https://dahanca.dk/uploads/TilFagfolk/Guideline/GUID_DAHANCA_Radiotherapy_guidelines_2020.pdf

DAHANCA (u.å.). DAHANCA 25 studierne – Styrketræning til hoved-halscancer patienter Aarhus: DAHANCA. Hentet fra https://www.dahanca.dk/uploads/TilFagfolk/Guideline/GUID_Styrketraening-tilhoved-halscancer.pdf

Dale, E., Moan, J. M., Osnes, T. A., & Bogsrud, T. V. (2017). Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome. European Archives of Oto-Rhino-Laryngology, 274(2), 1015-1019.

Dammann, F., Horger, M., Mueller-Berg, M., Schlemmer, H., Claussen, C. D., Hoffman, J., Eschmann, S., & Bares, R. (2005). Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR: American Journal of Roentgenology, 184(4), 1326-31.

de Bondt, R. B., Nelemans, P. J., Hofman, P. A., Casselman, J. W., Kremer, B., van Engelshoven, J. M., & Beets-Tan, R. G. (2007). Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. European Journal of Radiology, 64(2), 266-72.

De Crevoisier, R., Bourhis, J., Domenge, C., Wibault, P., Koscielny, S., Lusinchi, A., Mamelle, G., Janot, F., ... Eschwege, F. (1998). Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. Journal of Clinical Oncology, 16(11), 3556-62.

DeConti, R. C. (2012). Chemotherapy of squamous cell carcinoma of the skin. Seminars in Oncology, 39(2), 145-9.

DeConti, R. C., & Schoenfeld, D. (1981). A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer. Cancer, 48(5), 1061-72.

Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., ... Demetri, G. D. (2020). Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncology, 21(2), 271-282.

DSHHO, DAHANCA (2017). Kræft i næse og bihuler: nationale retningslinjer for udredning, behandling og rehabilitering af patienter med maligne tumorer i cavum nasi, de paranasale bihuler og vestibulum nasi Aarhus: Dansk Selskab for Hoved- og Hals Onkologi (DSHHO) og Dansk Hoved-hals Cancer Gruppe (DAHANCA).

Dulguerov, P., Allal, A. S., & Calcaterra, T. C. (2001). Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncology, 2(11), 683-90.

Duprez, F., Berwouts, D., Madani, I., Bonte, K., Boterberg, T., De Gersem, W., Deron, P., Huvenne, W., & De Neve, W. (2014). High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity. Radiotherapy and Oncology, 111(3), 388-92.

El-Naggar, A. K., Chan, J. K. C., Grandis, J. R., Slootweg, P. J. (2017). WHO classification of head and neck tumors. International Agency for Research on Cancer.

Eloy, J. A., Vivero, R. J., Hoang, K., Civantos, F. J., Weed, D. T., Morcos, J. J., & Casiano, R. R. (2009). Comparison of transnasal endoscopic and open craniofacial resection for malignant tumors of the anterior skull base. Laryngoscope, 119(5), 834-40.

Faisal, M., Abu Bakar, M., Sarwar, A., Adeel, M., Batool, F., Malik, K. I., Jamshed, A., & Hussain, R. (2018). Depth of invasion (DOI) as a predictor of cervical nodal metastasis and local recurrence in early stage squamous cell carcinoma of oral tongue (ESSCOT). PloS One, 13(8), e0202632.

Fakhry, N., Santini, L., Lagier, A., Dessi, P., & Giovanni, A. (2014). Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours. International Journal of Oral and Maxillofacial Surgery, 43(7), 802-5.

Faquin, W. C., Rossi, E. D., Baloch, Z., Barkan, G. A., Foschini, M. P., Kurtycz, D. F. J., ... Pusztaszeri, M. (2018). The Milan System for Reporting Salivary Gland Cytopathology. Springer.

Ferris, R. L. (2015). Immunology and Immunotherapy of Head and Neck Cancer. Journal of Clinical Oncology, 33(29), 3293-304.

Ferris, R. L., Flamand, Y., Weinstein, G. S., Li, S., Quon, H., Mehra, R., Garcia, J. J., Chung, C. H., ... Burtness, B. (2022). Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). Journal of Clinical Oncology, 40(2), 138-149.

Foulkes, W. D., Brunet, J. S., Sieh, W., Black, M. J., Shenouda, G., & Narod, S. A. (1996). Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ, 313(7059), 716-21.

Fowler, J., Campanile, Y., Warner, A., Laxague, F., Fnais, N., Fung, K., Mendez, A., MacNeil, D., ... Nichols, A. (2022). Surgical margins of the oral cavity: is 5 mm really necessary?. Journal of otolaryngology - head & neck surgery, 51(1), 38.

Frank, S. J., Rosenthal, D. I., Petsuksiri, J., Ang, K. K., Morrison, W. H., Weber, R. S., Glisson, B. S., Chao, K. S., ... Garden, A. S. (2010). Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. International Journal of Radiation Oncology, Biology, Physics, 78(4), 1005-10.

Frierson, H. F. ,. J., Mills, S. E., Fechner, R. E., Taxy, J. B., & Levine, P. A. (1986). Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. American Journal of Surgical Pathology, 10(11), 771-9.

Furness, S., Glenny, A. M., Worthington, H. V., Pavitt, S., Oliver, R., Clarkson, J. E., Macluskey, M., Chan, K. K., & Conway, D. I. (2011). Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane database of systematic reviews, (4), CD006386.

Fushimi, C., Tada, Y., Takahashi, H., Nagao, T., Ojiri, H., Masubuchi, T., Matsuki, T., Miura, K., ... Saotome, T. (2018). A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Annals of Oncology, 29(4), 979-984.

Galloway, T., Amdur, R. (2016). Management of late complications of head and neck cancer and its treatment. UpToDate [Database]. Waltham, MA: UpToDate, Inc. Hentet 30. juni 2016

Ganti, A. K., & Kessinger, A. (2011). Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treatment Reviews, 37(6), 440-3.

Gebre-Medhin, M., Brun, E., Engström, P., Haugen Cange, H., Hammarstedt-Nordenvall, L., Reizenstein, J., Nyman, J., Abel, E., ... Nilsson, P. (2021). ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer. Journal of Clinical Oncology, 39(1), 38-47.

Geiger, J. L., Ismaila, N., Beadle, B., Caudell, J. J., Chau, N., Deschler, D., Glastonbury, C., Kaufman, M., ... Ha, P. (2021). Management of Salivary Gland Malignancy: ASCO Guideline. Journal of Clinical Oncology, 39(17), 1909-1941.

Gilbert, J., Murphy, B. A., Jackson, L. (2016). Health-related quality of life in head and neck cancer. UpToDate [Database]. Waltham, MA: UpToDate, Inc. Hentet 30. juni 2016

Gillison, M. L., Trotti, A. M., Harris, J., Eisbruch, A., Harari, P. M., Adelstein, D. J., Jordan, R. C. K., Zhao, W., ... Le, Q. T. (2019). Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet, 393(10166), 40-50.

Glisson, B. S., Murphy, B. A., Frenette, G., Khuri, F. R., & Forastiere, A. A. (2002). Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. Journal of Clinical Oncology, 20(6), 1593-9.

Gore, A., Baugnon, K., Beitler, J., Saba, N. F., Patel, M. R., Wu, X., Boyce, B. J., & Aiken, A. H. (2020). Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?. AJNR: American Journal of Neuroradiology, 41(7), 1238-1244.

Govers, T. M., Hannink, G., Merkx, M. A., Takes, R. P., & Rovers, M. M. (2013). Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncology, 49(8), 726-32.

Grau, C., Johansen, L. V., Jakobsen, J., Geertsen, P., Andersen, E., & Jensen, B. B. (2000). Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiotherapy and Oncology, 55(2), 121-9.

Gray, S. T., Herr, M. W., Sethi, R. K., Diercks, G., Lee, L., Curry, W., Chan, A., Clark, J., ... Lin, D. T. (2015). Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Head and Neck, 37(3), 366-74.

Gregoire, V., Ang, K., Budach, W., Grau, C., Hamoir, M., Langendijk, J. A., Lee, A., Le, Q. T., ... Lengele, B. (2014). Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and Oncology, 110(1), 172-81.

Grégoire, V., Evans, M., Le, Q. T., Bourhis, J., Budach, V., Chen, A., Eisbruch, A., Feng, M., ... Grau, C. (2018). Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiotherapy and Oncology, 126(1), 3-24.

Grégoire, V., Giraud, P., Vieillevigne, L., & Maingon, P. (2022). Management of oropharyngeal squamous cell carcinoma. Cancer Radiotherapie, 26(1-2), 174-188.

Guan, J., Li, Q., Zhang, Y., Xiao, N., Chen, M., Zhang, Y., Li, L., & Chen, L. (2016). A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN). Oncotarget, 7(6), 7110-9.

Guardiola, E., Peyrade, F., Chaigneau, L., Cupissol, D., Tchiknavorian, X., Bompas, E., Madroszyk, A., Ronchin, P., ... Pivot, X. (2004). Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer. European Journal of Cancer, 40(14), 2071-6.

Guigay, J., Fayette, J., Mesia, R., Lafond, C., Saada-Bouzid, E., Geoffrois, L., Martin, L., Cupissol, D., ... Auperin, A. (2019). TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Journal of Clinical Oncology, 37(15_suppl), 6002.

Haehl, E., Rühle, A., David, H., Kalckreuth, T., Sprave, T., Stoian, R., Becker, C., Knopf, A., ... Nicolay, N. H. (2020). Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?. Radiation Oncology, 15(1), 31.

Hamauchi, S., Yokota, T., Onozawa, Y., Ogawa, H., Onoe, T., Kamijo, T., Iida, Y., Nishimura, T., ... Yasui, H. (2015). Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin. Jpn Journal of Clinical Oncology, 45(12), 1116-21.

Hanna, E. Y. (2008-2023). Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer [pågående studie]. (NCT00707473). Hentet fra https://www.clinicaltrials.gov/study/NCT00707473

Harabuchi, Y., Yamanaka, N., Kataura, A., Imai, S., Kinoshita, T., Mizuno, F., & Osato, T. (1990). Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335(8682), 128-30.

Harrington, K. J., Ferris, R. L., Blumenschein, G. ,. J., Colevas, A. D., Fayette, J., Licitra, L., Kasper, S., Even, C., ... Guigay, J. (2017). Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncology, 18(8), 1104-1115.

Hashibe, M., Brennan, P., Chuang, S. C., Boccia, S., Castellsague, X., Chen, C., Curado, M. P., Dal Maso, L., ... Boffetta, P. (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology, Biomarkers and Prevention, 18(2), 541-50.

Hassan Metwally, M. A., Ali, R., Kuddu, M., Shouman, T., Strojan, P., Iqbal, K., Prasad, R., Grau, C., & Overgaard, J. (2015). IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. Radiotherapy and Oncology, 116(1), 15-20.

Hayashi, K., Koto, M., Demizu, Y., Saitoh, J. I., Suefuji, H., Okimoto, T., Ohno, T., Shioyama, Y., ... Kamada, T. (2018). A retrospective multicenter study of carbon-ion radiotherapy for major salivary gland carcinomas: Subanalysis of J-CROS 1402 HN. Cancer Science, 109(5), 1576-1582.

Helsedirektoratet (2012). Veileder for utvikling av kunnskapsbaserte retningslinjer (IS-1870). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/veiledere/utvikling-av-kunnskapsbaserte-retningslinjer

Helsedirektoratet (2020). Seneffekter etter kreftbehandling: rapport (IS-2872). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/publikasjoner/seneffekter-etter-kreft

Hitt, R., Irigoyen, A., Cortes-Funes, H., Grau, J. J., Garcia-Saenz, J. A., & Cruz-Hernandez, J. J. (2012). Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Annals of Oncology, 23(4), 1016-22.

Ho, A. L., Foster, N. R., Zoroufy, A. J., Campbell, J. D., Worden, F., Price, K., Adkins, D., Bowles, D. W., ... Schwartz, G. K. (2022). Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). Journal of Clinical Oncology, 40(36), 4240-4249.

Ho, F. C., Tham, I. W., Earnest, A., Lee, K. M., & Lu, J. J. (2012). Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer, 12, 98.

Howard, D. J., Lund, V. J., & Wei, W. I. (2006). Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: a 25-year experience. Head and Neck, 28(10), 867-73.

Hughes, B. G. M., Munoz-Couselo, E., Mortier, L., Bratland, Å., Gutzmer, R., Roshdy, O., González Mendoza, R., Schachter, J., ... Grob, J. J. (2021). Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial. Annals of Oncology, 32(10), 1276-1285.

Hutchison, I. L., Ridout, F., Cheung, S. M. Y., Shah, N., Hardee, P., Surwald, C., Thiruchelvam, J., Cheng, L., ... Hackshaw, A. (2019). Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort. British Journal of Cancer, 121(10), 827-836.

Iannetti, G., Valentini, V., Rinna, C., Ventucci, E., & Marianetti, T. M. (2005). Ethmoido-orbital tumors: our experience. Journal of Craniofacial Surgery, 16(6), 1085-91.

Jacinto, J. K. M., Huang, S. H., Su, J., Kim, J., O'Sullivan, B., Ringash, J., Cho, J., Hope, A. J., ... Waldron, J. (2021). Clinical Behavior and Outcome of HPV-Positive Nasopharyngeal Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 111(3, Supplement), e384-e385.

Kaanders, J. H., Hordijk, G. J., & Dutch Cooperative Head and Neck Oncology Group (2002). Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitation. Radiotherapy and Oncology, 63(3), 299-307.

Kato, H., Kanematsu, M., Watanabe, H., Mizuta, K., & Aoki, M. (2014). Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components. Neuroradiology, 56(9), 789-95.

Kaufman, H. L., Russell, J., Hamid, O., Bhatia, S., Terheyden, P., D'Angelo, S. P., Shih, K. C., Lebbe, C., ... Nghiem, P. (2016). Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncology, 17(10), 1374-1385.

Keberle, M., Tschammler, A., & Hahn, D. (2002). Single-bolus technique for spiral CT of laryngopharyngeal squamous cell carcinoma: comparison of different contrast material volumes, flow rates, and start delays. Radiology, 224(1), 171-6.

Khan, L., Choo, R., Breen, D., Assaad, D., Fialkov, J., Antonyshyn, O., McKenzie, D., Woo, T., ... Barnes, E. (2012). Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer. Radiotherapy and Oncology, 104(2), 263-6.

Kim, B. S., Vongtama, R., & Juillard, G. (2004). Sinonasal undifferentiated carcinoma: case series and literature review. American Journal of Otolaryngology, 25(3), 162-6.

Kim, Y. S. (2017). Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence. Radiation oncology journal, 35(1), 1-15.

King, A. D., Ahuja, A. T., Leung, S. F., Lam, W. W., Teo, P., Chan, Y. L., & Metreweli, C. (2000). Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head and Neck, 22(3), 275-81.

Kiyota, N., Tahara, M., & Homma, A. (2024). Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck. Japanese Journal of Clinical Oncology, 54(6), 613-619.

Kiyota, N., Tahara, M., Mizusawa, J., Kodaira, T., Fujii, H., Yamazaki, T., Mitani, H., Iwae, S., ... Hayashi, R. (2022). Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial. Journal of Clinical Oncology, 40(18), 1980-1990.

Kolk, A., Wolff, K. D., Smeets, R., Kesting, M., Hein, R., & Eckert, A. W. (2014). Melanotic and non-melanotic malignancies of the face and external ear - A review of current treatment concepts and future options. Cancer Treatment Reviews, 40(7), 819-37.

König, M., Osnes, T., Jebsen, P., Evensen, J. F., & Meling, T. R. (2018). Olfactory neuroblastoma: a single-center experience. Neurosurgical Review, 41(1), 323-331.

König, M., Osnes, T., Jebsen, P., & Meling, T. R. (2018). Craniofacial resection of malignant tumors of the anterior skull base: a case series and a systematic review. Acta Neurochirurgica, 160(12), 2339-2348.

Koto, M., Demizu, Y., Saitoh, J. I., Suefuji, H., Tsuji, H., Okimoto, T., Ohno, T., Shioyama, Y., ... Kamada, T. (2017). Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). International Journal of Radiation Oncology, Biology, Physics, 97(5), 1054-1060.

Kramer, S., Gelber, R. D., Snow, J. B., Marcial, V. A., Lowry, L. D., Davis, L. W., & Chandler, R. (1987). Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head and Neck Surgery, 10(1), 19-30.

Krämer, A., Bochtler, T., Pauli, C., Baciarello, G., Delorme, S., Hemminki, K., Mileshkin, L., Moch, H., ... Fizazi, K. (2023). Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology, 34(3), 228-246.

Kwon, M., Roh, J. L., Lee, J., Cho, K. J., Choi, S. H., Nam, S. Y., & Kim, S. Y. (2015). Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma. Journal of Cranio-Maxillo-Facial Surgery, 43(6), 769-78.

Kyzas, P. A., Evangelou, E., Denaxa-Kyza, D., & Ioannidis, J. P. (2008). 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. Journal of the National Cancer Institute, 100(10), 712-20.

Lacas, B., Bourhis, J., Overgaard, J., Zhang, Q., Grégoire, V., Nankivell, M., Zackrisson, B., Szutkowski, Z., ... MARCH Collaborative Group (2017). Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncology, 18(9), 1221-1237.

Lacas, B., Carmel, A., Landais, C., Wong, S. J., Licitra, L., Tobias, J. S., Burtness, B., Ghi, M. G., ... Pignon, J. P. (2021). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group. Radiotherapy and Oncology, 156, 281-293.

Lagha, A., Chraiet, N., Ayadi, M., Krimi, S., Allani, B., Rifi, H., Raies, H., & Mezlini, A. (2012). Systemic therapy in the management of metastatic or advanced salivary gland cancers. Head & Neck Oncology, 4, 19.

Larsen, I. K. (2015). Cancer in Norway 2014: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Larsen, I. K. (2017). Cancer in Norway 2016: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Larsen, I. K. (2022). Cancer in Norway 2021: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Larsen, I. K. (2024). Cancer in Norway 2023: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Larønningen, S., Arvidsson, G., Bray, F., Dahl-Olsen, E. D., Engholm, G., Ervik, M., Friis, S. G. E. M., Gulbrandsen, J., Storm, H. H. (20. desember 2017). NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries. [nettressurs]. Lyon: NORDCAN: Association of the Nordic Cancer Registries og Cancer Registry of Norway. Hentet 14. februar 2018 fra http://www-dep.iarc.fr/nordcan.htm

Larønningen, S., Arvidsson, G., Bray, F., Dahl-Olsen, E. D., Engholm, G., Ervik, M., ... Friis, S. G. E. M. (2025). NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries [nettressurs]. (Data version: 9.5 - 19.06.2025). Lyon: NORDCAN: Association of the Nordic Cancer Registries og Cancer Registry of Norway. Hentet fra https://nordcan.iarc.fr/

Lechner, M., Liu, J., Masterson, L., & Fenton, T. R. (2022). HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nature reviews. Clinical oncology, 19(5), 306-327.

Lee, A. W., Ng, W. T., Pan, J. J., Poh, S. S., Ahn, Y. C., AlHussain, H., Corry, J., Grau, C., ... Wee, J. T. (2018). International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy and Oncology, 126(1), 25-36.

Lee, J. R., Kim, J. S., Roh, J. L., Lee, J. H., Baek, J. H., Cho, K. J., Choi, S. H., Nam, S. Y., & Kim, S. Y. (2015). Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study. Radiology, 274(3), 764-71.

Lee, Y. Y., Wong, K. T., King, A. D., & Ahuja, A. T. (2008). Imaging of salivary gland tumours. European Journal of Radiology, 66(3), 419-36.

Leong, S. P. (2011). Role of selective sentinel lymph node dissection in head and neck melanoma. Journal of Surgical Oncology, 104(4), 361-8.

Leslie, A., Fyfe, E., Guest, P., Goddard, P., & Kabala, J. E. (1999). Staging of squamous cell carcinoma of the oral cavity and oropharynx: a comparison of MRI and CT in T- and N-staging. Journal of Computer Assisted Tomography, 23(1), 43-9.

Levernes, S. (2019). Faglige anbefalinger for nomenklatur for volumer i stråleterapi (Teknisk dokument nummer 14). Østerås: Direktoratet for strålevern og atomsikkerhet. Hentet fra https://dsa.no/medisinsk-stralebruk/kvist/_/attachment/download/2f7317b7-e2f3-423e-b388-7d1d8d07b271:e947e054b123c9af0fa0fae10c867ce43e3d149e/TekniskDokument14.pdf

Li, H., Torabi, S. J., Yarbrough, W. G., Mehra, S., Osborn, H. A., & Judson, B. (2018). Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA otolaryngology-- head & neck surgery, 144(6), 519-525.

Liao, L. J., Lo, W. C., Hsu, W. L., Wang, C. T., & Lai, M. S. (2012). Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities. BMC Cancer, 12, 236.

Licitra, L., Nicolai, P., Calstelnuovo, P., Benazzo, M., Deantonio, L. (2013-2024). Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients [pågående studie]. (NCT02099188). Hentet fra https://www.clinicaltrials.gov/study/NCT02099188

Licitra, L., Nicolai, P., Calstelnuovo, P., Benazzo, M., Sponghini, A. (2013-2024). Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients [pågående studie]. (NCT02099175). Hentet fra https://www.clinicaltrials.gov/study/NCT02099175

Lindberg, R. (1972). Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer, 29(6), 1446-9.

Loevner, L. A., & Sonners, A. I. (2002). Imaging of neoplasms of the paranasal sinuses. Magnetic Resonance Imaging Clinics of North America, 10(3), 467-93.

Lonneux, M., Hamoir, M., Reychler, H., Maingon, P., Duvillard, C., Calais, G., Bridji, B., Digue, L., ... Gregoire, V. (2010). Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. Journal of Clinical Oncology, 28(7), 1190-5.

Lopez, F., Suárez, V., Vivanco, B., Suarez, C., & Llorente, J. L. (2015). Current management of sinonasal undifferentiated carcinoma. Rhinology, 53(3), 212-20.

López, F., Rodrigo, J. P., Silver, C. E., Haigentz, M. ,. J., Bishop, J. A., Strojan, P., Hartl, D. M., Bradley, P. J., ... Ferlito, A. (2016). Cervical lymph node metastases from remote primary tumor sites. Head and Neck, 38 Suppl 1, E2374-85.

Lund, V. J., Clarke, P. M., Swift, A. C., McGarry, G. W., Kerawala, C., & Carnell, D. (2016). Nose and paranasal sinus tumours: United Kingdom National Multidisciplinary Guidelines. Journal of Laryngology and Otology, 130(S2), S111-s118.

Lydiatt, W. M., Patel, S. G., O'Sullivan, B., Brandwein, M. S., Ridge, J. A., Migliacci, J. C., Loomis, A. M., & Shah, J. P. (2017). Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians, 67(2), 122-137.

Maare, C., Kjeldsen, R., Jensen, K., Andersen, M., Andersen, E., & Johansen, J. (2014). PO-0666: High dose hypofractionated radiotherapy for treatment and palliation of head and neck cancer patients. Radiotherapy and Oncology, 111(Suppl 1), S8.

Machiels, J. P., René Leemans, C., Golusinski, W., Grau, C., Licitra, L., & Gregoire, V. (2020). Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 31(11), 1462-1475.

Maghami, E., Ismaila, N., Alvarez, A., Chernock, R., Duvvuri, U., Geiger, J., Gross, N., Haughey, B., ... Caudell, J. (2020). Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline. Journal of Clinical Oncology, 38(22), 2570-2596.

Mahler, V., Boysen, M., & Brøndbo, K. (2010). Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma?. European Archives of Oto-Rhino-Laryngology, 267(5), 743-50.

Mahmood, U., Koshy, M., Goloubeva, O., & Suntharalingam, M. (2011). Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors. Archives of Otolaryngology - Head and Neck Surgery, 137(10), 1025-30.

Martin, J. M., & Galloway, T. J. (2015). Evaluation and management of head and neck squamous cell carcinoma of unknown primary. Surgical Oncology Clinics of North America, 24(3), 579-91.

Matuschek, C., Haussmann, J., Bölke, E., Gripp, S., Schuler, P. J., Tamaskovics, B., Gerber, P. A., Djiepmo-Njanang, F. J., ... Budach, W. (2018). Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis. Radiation Oncology, 13(1), 195.

Maubec, E., Petrow, P., Scheer-Senyarich, I., Duvillard, P., Lacroix, L., Gelly, J., Certain, A., Duval, X., ... Avril, M. F. (2011). Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. Journal of Clinical Oncology, 29(25), 3419-26.

Mehanna, H., Robinson, M., Hartley, A., Kong, A., Foran, B., Fulton-Lieuw, T., Dalby, M., Mistry, P., ... Dunn, J. (2019). Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet, 393(10166), 51-60.

Mehanna, H., Taberna, M., von Buchwald, C., Tous, S., Brooks, J., Mena, M., Morey, F., Grønhøj, C., ... Alemany, L. (2023). Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncology, 24(3), 239-251.

Mehanna, H., Wong, W. L., McConkey, C. C., Rahman, J. K., Robinson, M., Hartley, A. G., Nutting, C., Powell, N., ... Group, P. T. M. (2016). PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. New England Journal of Medicine, 374(15), 1444-54.

Meites, E., Stone, L., Amiling, R., Singh, V., Unger, E. R., Derkay, C. S., & Markowitz, L. E. (2021). Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States. Clinical Infectious Diseases, 73(5), 885-890.

Mendenhall, W. M., Morris, C. G., Amdur, R. J., Werning, J. W., & Villaret, D. B. (2005). Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer, 103(12), 2544-50.

Merck Sharp & Dohme LLC (2017-2023). Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629) [pågående studie]. (NCT03284424). Hentet fra https://www.clinicaltrials.gov/study/NCT03284424

Merino, O. R., Lindberg, R. D., & Fletcher, G. H. (1977). An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer, 40(1), 145-51.

Migden, M. R., Rischin, D., Schmults, C. D., Guminski, A., Hauschild, A., Lewis, K. D., Chung, C. H., Hernandez-Aya, L., ... Fury, M. G. (2018). PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. New England Journal of Medicine, 379(4), 341-351.

Morris, L. G., Sikora, A. G., Patel, S. G., Hayes, R. B., & Ganly, I. (2011). Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. Journal of Clinical Oncology, 29(6), 739-46.

Mourad, W. F., Hauerstock, D., Shourbaji, R. A., Hu, K. S., Culliney, B., Li, Z., Jacobson, A., Tran, T., ... Harrison, L. B. (2013). Trimodality management of sinonasal undifferentiated carcinoma and review of the literature. American Journal of Clinical Oncology, 36(6), 584-8.

Mukherjee, S., Fischbein, N. J., Baugnon, K. L., Policeni, B. A., & Raghavan, P. (2023). Contemporary Imaging and Reporting Strategies for Head and Neck Cancer: MRI, FDG PET/MRI, NI-RADS, and Carcinoma of Unknown Primary-AJR Expert Panel Narrative Review. AJR: American Journal of Roentgenology, 220(2), 160-172.

Müller von der Grün, J., Martin, D., Stöver, T., Ghanaati, S., Rödel, C., & Balermpas, P. (2018). Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer. BioMed research international, 2018, 3508795.

Müller von der Grün, J., Tahtali, A., Ghanaati, S., Rödel, C., & Balermpas, P. (2017). Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site – current status and challenges. Radiation Oncology, 12(1), 82.

Näsman, A., Attner, P., Hammarstedt, L., Du, J., Eriksson, M., Giraud, G., Ahrlund-Richter, S., Marklund, L., ... Dalianis, T. (2009). Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. International Journal of Cancer, 125(2), 362-6.

NCCN (2015). Head and neck cancers. Version 1.2015 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.

NCCN (2018). Ethmoid sinus tumors; Maxillary sinus. I: Head and neck cancers. Version 2.2018 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.

NCCN (2018). Head and neck cancers. Version 2.2018 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.

NCCN (2025). Head and neck cancers. Version 2.2025 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.

Ndiaye, C., Mena, M., Alemany, L., Arbyn, M., Castellsagué, X., Laporte, L., Bosch, F. X., de Sanjose, S., & Trottier, H. (2014). HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncology, 15(12), 1319-31.

Nguyen-Tan, P. F., Zhang, Q., Ang, K. K., Weber, R. S., Rosenthal, D. I., Soulieres, D., Kim, H., Silverman, C., ... Le, Q. T. (2014). Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. Journal of Clinical Oncology, 32(34), 3858-66.

NICE (2004). Guidance on cancer services: improving outcomes in head and neck cancers: the manual London: National Institute for Clinical Excellence. Hentet fra https://www.nice.org.uk/guidance/csg6/resources/improving-outcomes-in-head-and-neck-cancers-update-pdf-773377597

Nichols, A. C., Theurer, J., Prisman, E., Read, N., Berthelet, E., Tran, E., Fung, K., de Almeida, J. R., ... Palma, D. A. (2022). Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. Journal of Clinical Oncology, 40(8), 866-875.

Nichols, A. C., Theurer, J., Prisman, E., Read, N., Berthelet, E., Tran, E., Fung, K., de Almeida, J. R., ... Palma, D. A. (2024). Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial. Journal of Clinical Oncology, 42(34), 4023-4028.

Nicolaidou, E., Mikrova, A., Antoniou, C., & Katsambas, A. D. (2012). Advances in Merkel cell carcinoma pathogenesis and management: a recently discovered virus, a new international consensus staging system and new diagnostic codes. British Journal of Dermatology, 166(1), 16-21.

Nishio, N., Fujimoto, Y., Fujii, M., Saito, K., Hiramatsu, M., Maruo, T., Iwami, K., Kamei, Y., ... Nakashima, T. (2015). Craniofacial Resection for T4 Maxillary Sinus Carcinoma: Managing Cases with Involvement of the Skull Base. Otolaryngology and Head and Neck Surgery, 153(2), 231-8.

Noronha, V., Joshi, A., Patil, V. M., Agarwal, J., Laskar, S. G., Budrukkar, A. N., Murthy, V., & Gupta, T. (2017). Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer. Journal of Clinical Oncology, 35(15 suppl), 6007.

Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., Miles, E. A., Miah, A. B., ... Hall, E. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncology, 12(2), 127-36.

Nuyts, S., Bollen, H., Ng, S. P., Corry, J., Eisbruch, A., Mendenhall, W. M., Smee, R., Strojan, P., ... Ferlito, A. (2022). Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges. Cancers, 14(11)

Nyrud, M. K., Bratland, Å., Landrø, L., Brevig, T., Ryder, T., Hermann, R., & Frich, L. (2022). Merkel cell carcinoma. Tidsskrift for den Norske Legeforening, 142(9)

O'Sullivan, B., Huang, S. H., Su, J., Garden, A. S., Sturgis, E. M., Dahlstrom, K., Lee, N., Riaz, N., ... Xu, W. (2016). Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncology, 17(4), 440-451.

Overgaard, J., Hansen, H. S., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. (1998). A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiotherapy and Oncology, 46(2), 135-46.

Overgaard, J., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Andersen, E., Bentzen, J., Bastholt, L., ... Evensen, J. F. (2003). Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet, 362(9388), 933-40.

Palma, D. A., Prisman, E., Berthelet, E., Tran, E., Hamilton, S., Wu, J., Eskander, A., Higgins, K., ... Nichols, A. C. (2022). Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial. JAMA oncology, 8(6), 845-851.

Patel, S. G., Prasad, M. L., Escrig, M., Singh, B., Shaha, A. R., Kraus, D. H., Boyle, J. O., Huvos, A. G., ... Shah, J. P. (2002). Primary mucosal malignant melanoma of the head and neck. Head and Neck, 24(3), 247-57.

Patel, S. G., Singh, B., Polluri, A., Bridger, P. G., Cantu, G., Cheesman, A. D., deSa, G. M., Donald, P., ... Shah, J. P. (2003). Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer, 98(6), 1179-87.

Patel, S. G., Singh, B., Stambuk, H. E., Carlson, D., Bridger, P. G., Cantu, G., Cheesman, A. D., Donald, P., ... Shah, J. P. (2012). Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. Journal of neurological surgery. Part B, Skull base, 73(3), 208-20.

Patel, S. H., Wang, Z., Wong, W. W., Murad, M. H., Buckey, C. R., Mohammed, K., Alahdab, F., Altayar, O., ... Foote, R. L. (2014). Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncology, 15(9), 1027-38.

Patel, T. R., Eggerstedt, M., Toor, J., Tajudeen, B. A., Husain, I., Stenson, K., & Al-Khudari, S. (2021). Occult Lymph Node Metastasis in Early-Stage Glottic Cancer in the National Cancer Database. Laryngoscope, 131(4), E1139-e1146.

Pathak, I., O'Brien, C. J., Petersen-Schaeffer, K., McNeil, E. B., McMahon, J., Quinn, M. J., Thompson, J. F., & McCarthy, W. H. (2001). Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern?. Head and Neck, 23(9), 785-90.

Petit, C., Lacas, B., Pignon, J. P., Le, Q. T., Grégoire, V., Grau, C., Hackshaw, A., Zackrisson, B., ... Blanchard, P. (2021). Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. Lancet Oncology, 22(5), 727-736.

Pignon, J. P., Bourhis, J., Domenge, C., & Designé, L. (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet, 355(9208), 949-55.

Pignon, J. P., le Maître, A., Maillard, E., Bourhis, J., & MACH-NC Collaborative Group (2009). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology, 92(1), 4-14.

Porceddu, S. V., Rosser, B., Burmeister, B. H., Jones, M., Hickey, B., Baumann, K., Gogna, K., Pullar, A., ... Holt, T. (2007). Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial". Radiotherapy and Oncology, 85(3), 456-62.

Prowse, S. J., Shaw, R., Ganeshan, D., Prowse, P. M., Hanlon, R., Lewis-Jones, H., & Wieshmann, H. (2013). The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy. Journal of Laryngology and Otology, 127(8), 780-7.

Raghavan, U., Quraishi, S., & Bradley, P. J. (2003). Multiple primary tumors in patients diagnosed with hypopharyngeal cancer. Otolaryngology and Head and Neck Surgery, 128(3), 419-25.

Reiersen, D. A., Pahilan, M. E., & Devaiah, A. K. (2012). Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngology and Head and Neck Surgery, 147(1), 7-14.

Riaz, N., Morris, L. G., Lee, W., & Chan, T. A. (2014). Unraveling the molecular genetics of head and neck cancer through genome-wide approaches. Genes & diseases, 1(1), 75-86.

Robbins, K. T., Clayman, G., Levine, P. A., Medina, J., Sessions, R., Shaha, A., Som, P., & Wolf, G. T. (2002). Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Archives of Otolaryngology - Head and Neck Surgery, 128(7), 751-8.

Roscher, I., Brevig, T., Mørk, G., Helsing, P., & Gjersvik, P. (2011). Mohs’ kirurgi ved basalcellekarsinom i ansiktet. Tidsskrift for den Norske Legeforening, 131(24), 2475-9.

Rusthoven, K. E., Koshy, M., & Paulino, A. C. (2004). The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer, 101(11), 2641-9.

Sakata, K., Maeda, A., Rikimaru, H., Ono, T., Koga, N., Takeshige, N., Tokutomi, T., Umeno, H., ... Morioka, M. (2016). Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management. World Neurosurgery, 89, 240-54.

Saku, T., Hayashi, Y., Takahara, O., Matsuura, H., Tokunaga, M., Tokunaga, M., Tokuoka, S., Soda, M., ... Land, C. E. (1997). Salivary gland tumors among atomic bomb survivors, 1950-1987. Cancer, 79(8), 1465-75.

Schneider, A. B., Lubin, J., Ron, E., Abrahams, C., Stovall, M., Goel, A., Shore-Freedman, E., & Gierlowski, T. C. (1998). Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiation Research, 149(6), 625-30.

Schoffski, P., Catimel, G., Planting, A. S., Droz, J. P., Verweij, J., Schrijvers, D., Gras, L., Schrijvers, A., ... Hanauske, A. R. (1999). Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group. Annals of Oncology, 10(1), 119-22.

Sekretariatet for nye metoder (25. april 2022). Cemiplimab (Libtayo) - Indikasjon II. Nye metoder [nettdokument]. Hamar: Helse Sør-Øst RHF. Hentet 6. juli 2023 fra https://nyemetoder.no/metoder/cemiplimab-libtayo-indikasjon-ii

Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., ... Hauschild, A. (2012). Efficacy and safety of vismodegib in advanced basal-cell carcinoma. New England Journal of Medicine, 366(23), 2171-9.

Shahid Iqbal, M., Kelly, C., Kovarik, J., Goranov, B., Shaikh, G., Morgan, D., Dobrowsky, W., & Paleri, V. (2018). Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review. Radiotherapy and Oncology, 126(3), 558-567.

Shebl, F. M., Bhatia, K., & Engels, E. A. (2010). Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. International Journal of Cancer, 126(10), 2503-8.

Sigal, R., Zagdanski, A. M., Schwaab, G., Bosq, J., Auperin, A., Laplanche, A., Francke, J. P., Eschwege, F., ... Vanel, D. (1996). CT and MR imaging of squamous cell carcinoma of the tongue and floor of the mouth. Radiographics, 16(4), 787-810.

Singh, N., Eskander, A., Huang, S. H., Curtin, H., Bartlett, E., Vescan, A., Kraus, D., O'Sullivan, B., ... Yu, E. (2013). Imaging and resectability issues of sinonasal tumors. Expert Review of Anticancer Therapy, 13(3), 297-312.

Skálová, A., Stenman, G., Simpson, R. H. W., Hellquist, H., Slouka, D., Svoboda, T., Bishop, J. A., Hunt, J. L., ... Ferlito, A. (2018). The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. American Journal of Surgical Pathology, 42(2), e11-e27.

Solomon, J., Hinther, A., Matthews, T. W., Nakoneshny, S. C., Hart, R., Dort, J. C., & Chandarana, S. P. (2021). The impact of close surgical margins on recurrence in oral squamous cell carcinoma. Journal of otolaryngology - head & neck surgery, 50(1), 9.

Specht, L., Larsen, S. K., & Hansen, H. S. (2000). Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. Annals of Oncology, 11(7), 845-9.

Spencer, S. A., Harris, J., Wheeler, R. H., Machtay, M., Schultz, C., Spanos, W., Rotman, M., Meredith, R., & Ang, K. K. (2008). Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head and Neck, 30(3), 281-8.

Storaas, E., Switlyk, M. D., Dahl, S., Amdal, C. D., Bratland, Å., Huynh, T. M., Eide, H. A., Vischioni, B., ... Dale, E. (2025). Distinct patterns of osteoradionecrosis after photon-based radiotherapy and carbon ion radiotherapy for unresectable adenoid cystic carcinoma of the head and neck: case series from two institutions. Acta Oncologica, 64, 63-68.

Stratigos, A. J., Sekulic, A., Peris, K., Bechter, O., Prey, S., Kaatz, M., Lewis, K. D., Basset-Seguin, N., ... Fury, M. G. (2021). Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Lancet Oncology, 22(6), 848-857.

Strojan, P., Corry, J., Eisbruch, A., Vermorken, J. B., Mendenhall, W. M., Lee, A. W., Haigentz, M. ,. J., Beitler, J. J., ... Ferlito, A. (2015). Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head and Neck, 37(1), 134-50.

Strojan, P., Ferlito, A., Langendijk, J. A., Corry, J., Woolgar, J. A., Rinaldo, A., Silver, C. E., Paleri, V., ... Barnes, L. (2013). Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head and Neck, 35(2), 286-93.

Strojan, P., Ferlito, A., Medina, J. E., Woolgar, J. A., Rinaldo, A., Robbins, K. T., Fagan, J. J., Mendenhall, W. M., ... Barnes, L. (2013). Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head and Neck, 35(1), 123-32.

Subbiah, V., Wolf, J., Konda, B., Kang, H., Spira, A., Weiss, J., Takeda, M., Ohe, Y., ... Drilon, A. (2022). Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. Lancet Oncology, 23(10), 1261-1273.

Sulaiman, N. S., Demizu, Y., Koto, M., Saitoh, J. I., Suefuji, H., Tsuji, H., Ohno, T., Shioyama, Y., ... Kamada, T. (2018). Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). International Journal of Radiation Oncology, Biology, Physics, 100(3), 639-646.

Sun, J., Li, B., Li, C. J., Li, Y., Su, F., Gao, Q. H., Wu, F. L., Yu, T., ... Li, L. J. (2015). Computed tomography versus magnetic resonance imaging for diagnosing cervical lymph node metastasis of head and neck cancer: a systematic review and meta-analysis. OncoTargets and Therapy, 8, 1291-313.

Sundhedsstyrelsen (2015). Opfølgningsprogram for hoved- og halskræft København: Sundhedsstyrelsen. Hentet fra https://www.dahanca.dk/uploads/TilFagfolk/Guideline/GUID_Opfolgningsprogram_for_hovedhalskraeft_2015.pdf

Szturz, P., Wouters, K., Kiyota, N., Tahara, M., Prabhash, K., Noronha, V., Castro, A., Licitra, L., ... Vermorken, J. B. (2017). Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data. Oncologist, 22(9), 1056-1066.

Tajudeen, B. A., Arshi, A., Suh, J. D., St John, M., & Wang, M. B. (2014). Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA otolaryngology-- head & neck surgery, 140(12), 1124-9.

Takahashi, H., Tada, Y., Saotome, T., Akazawa, K., Ojiri, H., Fushimi, C., Masubuchi, T., Matsuki, T., ... Nagao, T. (2019). Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma. Journal of Clinical Oncology, 37(2), 125-134.

Takes, R. P., Rinaldo, A., Silver, C. E., Haigentz, M. ,. J., Woolgar, J. A., Triantafyllou, A., Mondin, V., Paccagnella, D., ... Ferlito, A. (2012). Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncology, 48(9), 775-9.

Tambas, M., Steenbakkers, R., van der Laan, H. P., Wolters, A. M., Kierkels, R. G. J., Scandurra, D., Korevaar, E. W., Oldehinkel, E., ... Langendijk, J. A. (2020). First experience with model-based selection of head and neck cancer patients for proton therapy. Radiotherapy and Oncology, 151, 206-213.

Tambas, M., van der Laan, H. P., Steenbakkers, R., Doyen, J., Timmermann, B., Orlandi, E., Hoyer, M., Haustermans, K., ... Langendijk, J. A. (2022). Current practice in proton therapy delivery in adult cancer patients across Europe. Radiotherapy and Oncology, 167, 7-13.

Tanzler, E. D., Amdur, R. J., Morris, C. G., Werning, J. W., & Mendenhall, W. M. (2016). Challenging the need for random directed biopsies of the nasopharynx, pyriform sinus, and contralateral tonsil in the workup of unknown primary squamous cell carcinoma of the head and neck. Head and Neck, 38(4), 578-81.

Tchekmedyian, V., Sherman, E. J., Dunn, L., Tran, C., Baxi, S., Katabi, N., Antonescu, C. R., Ostrovnaya, I., ... Ho, A. L. (2019). Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma. Journal of Clinical Oncology, 37(18), 1529-1537.

Telfer, N. R., Colver, G. B., & Morton, C. A. (2008). Guidelines for the management of basal cell carcinoma. British Journal of Dermatology, 159(1), 35-48.

Terhaard, C. H., Lubsen, H., Rasch, C. R., Levendag, P. C., Kaanders, H. H., Tjho-Heslinga, R. E., van Den Ende, P. L., & Burlage, F. (2005). The role of radiotherapy in the treatment of malignant salivary gland tumors. International Journal of Radiation Oncology, Biology, Physics, 61(1), 103-11.

Toustrup, K., Sørensen, B. S., Alsner, J., & Overgaard, J. (2012). Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy. Seminars in Radiation Oncology, 22(2), 119-27.

Valstar, M. H., van den Brekel, M. W., & Smeele, L. E. (2010). Interpretation of treatment outcome in the clinically node-negative neck in primary parotid carcinoma: a systematic review of the literature. Head and Neck, 32(10), 1402-11.

van Boxtel, W., Locati, L. D., van Engen-van Grunsven, A. C. H., Bergamini, C., Jonker, M. A., Fiets, E., Cavalieri, S., Tooten, S., ... van Herpen, C. M. L. (2019). Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma. European Journal of Cancer, 110, 62-70.

Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., ... Hitt, R. (2008). Platinum-based chemotherapy plus cetuximab in head and neck cancer. New England Journal of Medicine, 359(11), 1116-27.

Vermorken, J. B., Trigo, J., Hitt, R., Koralewski, P., Diaz-Rubio, E., Rolland, F., Knecht, R., Amellal, N., ... Baselga, J. (2007). Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. Journal of Clinical Oncology, 25(16), 2171-7.

von Buchwald, C., & Bradley, P. J. (2007). Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Current Opinion in Otolaryngology & Head and Neck Surgery, 15(2), 95-8.

Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., Weiss, G. J., Borad, M. J., ... Low, J. A. (2009). Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. New England Journal of Medicine, 361(12), 1164-72.

Vrionis, F. D., Kienstra, M. A., Rivera, M., & Padhya, T. A. (2004). Malignant tumors of the anterior skull base. Cancer Control, 11(3), 144-51.

Wang, C. C. (1994). To reirradiate or not to reirradiate?. International Journal of Radiation Oncology, Biology, Physics, 29(4), 913; discussion 919.

Wang, T. S., Byrne, P. J., Jacobs, L. K., & Taube, J. M. (2011). Merkel cell carcinoma: update and review. Seminars in Cutaneous Medicine and Surgery, 30(1), 48-56.

Wang, W. Y., Twu, C. W., Chen, H. H., Jiang, R. S., Wu, C. T., Liang, K. L., Shih, Y. T., Chen, C. C., ... Lin, J. C. (2013). Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels. Cancer, 119(5), 963-70.

Wangaryattawanich, P., Anzai, Y., Mead-Harvey, C., Almader-Douglas, D., & Rath, T. J. (2024). Does Long-term Surveillance Imaging Improve Survival in Patients Treated for Head and Neck Squamous Cell Carcinoma? A Systematic Review of the Current Evidence. AJNR: American Journal of Neuroradiology,

Ward, M. C., Prabhu, R. S., Atlas, J. L., Carrizosa, D. R., Milas, Z. L., Brickman, D. S., Frenkel, C. H., Hong, S. S., & Moeller, B. J. (2024). Weekly Versus Bolus Cisplatin Concurrent With Definitive Radiation Therapy for Squamous Carcinoma of the Head and Neck: A Systematic Review and Network Meta-Analysis. Practical Radiation Oncology, 14(6), e458-e466.

Watanabe, A., Taniguchi, M., Tsujie, H., Hosokawa, M., Fujita, M., & Sasaki, S. (2009). The value of narrow band imaging for early detection of laryngeal cancer. European Archives of Oto-Rhino-Laryngology, 266(7), 1017-23.

Watkinson, J. C., Clarke, R. W. (2018). Scott-Brown's Otorhinolaryngology and Head and Neck Surgery: Volume 3: Head and Neck Surgery, Plastic Surgery. CRC Press.

Weissman, J. L., & Carrau, R. L. (2001). "Puffed-cheek" CT improves evaluation of the oral cavity. AJNR: American Journal of Neuroradiology, 22(4), 741-4.

Westergaard-Nielsen, M., Rohde, M., Godballe, C., Eriksen, J. G., Larsen, S. R., Gerke, O., Nguyen, N., Nielsen, M. K., ... Bjorndal, K. (2019). Up-front F18-FDG PET/CT in suspected salivary gland carcinoma. Annals of Nuclear Medicine, 33(8), 554-563.

WHO Classification of Tumours Editorial Board (Under publisering 2022). WHO classification of head and neck tumors. International Agency for Research on Cancer.

Wong, L. Y., Lam, L. K., Fan, Y. W., Yuen, A. P., & Wei, W. I. (2006). Outcome analysis of patients with craniofacial resection: Hong Kong experience. ANZ Journal of Surgery, 76(5), 313-7.

Wong, S. L., Balch, C. M., Hurley, P., Agarwala, S. S., Akhurst, T. J., Cochran, A., Cormier, J. N., Gorman, M., ... Lyman, G. H. (2012). Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Journal of Clinical Oncology, 30(23), 2912-8.

Wreesmann, V. B., Katabi, N., Palmer, F. L., Montero, P. H., Migliacci, J. C., Gonen, M., Carlson, D., Ganly, I., ... Patel, S. G. (2016). Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head and Neck, 38 Suppl 1, E1192-9.

Wu, L. M., Xu, J. R., Liu, M. J., Zhang, X. F., Hua, J., Zheng, J., & Hu, J. N. (2012). Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis. Academic Radiology, 19(3), 331-40.

Xing, Y., Bronstein, Y., Ross, M. I., Askew, R. L., Lee, J. E., Gershenwald, J. E., Royal, R., & Cormier, J. N. (2011). Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. Journal of the National Cancer Institute, 103(2), 129-42.

Xu, G., Li, J., Zuo, X., & Li, C. (2012). Comparison of whole body positron emission tomography (PET)/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: a meta-analysis. Laryngoscope, 122(9), 1974-8.

Xu, J., & Cao, Y. (2014). Radiation-induced carotid artery stenosis: a comprehensive review of the literature. Interventional neurology, 2(4), 183-92.

Yoo, J., Henderson, S., & Walker-Dilks, C. (2013). Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer. Clinical Oncology (Royal College of Radiologists), 25(4), e33-66.

Zhang, Y., Chen, L., Hu, G. Q., Zhang, N., Zhu, X. D., Yang, K. Y., Jin, F., Shi, M., ... Ma, J. (2019). Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. New England Journal of Medicine, 381(12), 1124-1135.

Zhu, L., & Wang, N. (2013). 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis. Surgical Oncology, 22(3), 190-4.

Zubair, F., Farooq, S., Wright, S., Schipani, S., & McMahon, J. (2022). Patterns of recurrence amongst patients undergoing resection of oral squamous cell carcinoma with curative intent. The British journal of oral & maxillofacial surgery, 60(10), 1379-1384.